Health · 2 views
Nanobody Shows Promise in Myasthenia Gravis
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab…
Summary
(MedPage Today) -- Results from the phase III PREVAIL trial presented at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting showed that treatment with the investigational once-weekly nanobody gefurulimab significantly
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- HIV activism offers a roadmap for tackling weight stigmaContinue reading
- Another Drug Shows Potential for Functional Cures in Chronic Hepatitis BContinue reading
- Alzheimer's discovery reveals brain cleaning gone wrongContinue reading
- People in deprived areas of England more than twice as likely to die early, study showsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow